Resultats de la cerca - Kabbinavar, Fairooz
- Mostrar 1 - 20 resultats de 21
- Anar a la pàgina següent
-
1
HBI-8000, HUYABIO Lead Clinical Program, Is a Selective Histone Deacetylase Inhibitor With Therapeutic Benefits in Leukemia and in Solid Tumors per Shojaei, Farbod, Goodenow, Bob, Lee, Gloria, Kabbinavar, Fairooz, Gillings, Mireille
Publicat 2022Text -
2
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies per Cassidy, James, Saltz, Leonard B., Giantonio, Bruce J., Kabbinavar, Fairooz F., Hurwitz, Herbert I., Rohr, Ulrich-Peter
Publicat 2009Text -
3
Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab per Ather, Ferdows, Hamidi, Habib, Fejzo, Marlena S., Letrent, Stephen, Finn, Richard S., Kabbinavar, Fairooz, Head, Christian, Wong, Steven G.
Publicat 2013Text -
4
A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small... per Garon, Edward B, Neidhart, Jeffrey D, Gabrail, Nashat Y, de Oliveira, Moacyr R, Balkissoon, Jai, Kabbinavar, Fairooz
Publicat 2016Text -
5
Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials per Hurwitz, Herbert I., Tebbutt, Niall C., Kabbinavar, Fairooz, Giantonio, Bruce J., Guan, Zhong-Zhen, Mitchell, Lada, Waterkamp, Daniel, Tabernero, Josep
Publicat 2013Text -
6
-
7
Histologic Evaluation of Metastases in Renal Cell Carcinoma With Sarcomatoid Transformation and Its Implications for Systemic Therapy per Shuch, Brian, Said, Jonathan, LaRochelle, Jeffrey C., Zhou, Ying, Li, Gang, Klatte, Tobias, Pouliot, Frederic, Kabbinavar, Fairooz F., Belldegrun, Arie S., Pantuck, Allan J.
Publicat 2010Text -
8
A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non–Small-Cell Lung Cancer per Hirsch, Fred R., Kabbinavar, Fairooz, Eisen, Tim, Martins, Renato, Schnell, Fredrick M., Dziadziuszko, Rafal, Richardson, Katherine, Richardson, Frank, Wacker, Bret, Sternberg, David W., Rusk, Jason, Franklin, Wilbur A., Varella-Garcia, Marileila, Bunn, Paul A., Camidge, D. Ross
Publicat 2011Text -
9
Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial per Herbst, Roy S, Sun, Yan, Eberhardt, Wilfried E E, Germonpré, Paul, Saijo, Nagahiro, Zhou, Caicun, Wang, Jie, Li, Longyun, Kabbinavar, Fairooz, Ichinose, Yukito, Qin, Shukui, Zhang, Li, Biesma, Bonne, Heymach, John V, Langmuir, Peter, Kennedy, Sarah J, Tada, Hiroomi, Johnson, Bruce E
Publicat 2010Text -
10
Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer per Garon, Edward B., Christofk, Heather R., Hosmer, Wylie, Britten, Carolyn D, Bahng, Agnes, Crabtree, Matthew J, Hong, Candice Sun, Kamranpour, Naeimeh, Pitts, Sharon, Kabbinavar, Fairooz, Patel, Cecil, von Euw, Erika, Black, Alexander, Michelakis, Evangelos D., Dubinett, Steven M., Slamon, Dennis J.
Publicat 2014Text -
11
Dendritic Cell-Based Immunotherapy in Prevention and Treatment of Renal Cell Carcinoma: Efficacy, Safety, and Activity of Ad-GM∙CAIX in Immunocompetent Mouse Models per Birkhäuser, Frédéric D, Koya, Richard C, Neufeld, Caleb, Rampersaud, Edward N, Lu, Xuyang, Micewicz, Ewa D, Chodon, Thinle, Atefi, Mohammad, Kroeger, Nils, Chandramouli, Gadisetti VR, Li, Gang, Said, Jonathan W, McBride, William H, Kabbinavar, Fairooz F, Ribas, Antoni, Pantuck, Allan J, Belldegrun, Arie S, Riss, Joseph
Publicat 2013Text -
12
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial per Hurvitz, Sara A., Saura, Cristina, Oliveira, Mafalda, Trudeau, Maureen E., Moy, Beverly, Delaloge, Suzette, Gradishar, William, Kim, Sung‐Bae, Haley, Barbara, Ryvo, Larisa, Dai, Ming‐Shen, Milovanov, Vladimir, Alarcón, Jesús, Kalmadi, Sujith, Cronemberger, Eduardo, Souza, Cristiano, Landeiro, Luciana, Bose, Ron, Bebchuk, Judith, Kabbinavar, Fairooz, Bryce, Richard, Keyvanjah, Kiana, Brufsky, Adam M.
Publicat 2021Text -
13
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial per Rittmeyer, Achim, Barlesi, Fabrice, Waterkamp, Daniel, Park, Keunchil, Ciardiello, Fortunato, von Pawel, Joachim, Gadgeel, Shirish M, Hida, Toyoaki, Kowalski, Dariusz M, Dols, Manuel Cobo, Cortinovis, Diego L, Leach, Joseph, Polikoff, Jonathan, Barrios, Carlos, Kabbinavar, Fairooz, Frontera, Osvaldo Arén, De Marinis, Filippo, Turna, Hande, Lee, Jong-Seok, Ballinger, Marcus, Kowanetz, Marcin, He, Pei, Chen, Daniel S, Sandler, Alan, Gandara, David R
Publicat 2016Text -
14
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Random... per Cloughesy, Timothy F., Petrecca, Kevin, Walbert, Tobias, Butowski, Nicholas, Salacz, Michael, Perry, James, Damek, Denise, Bota, Daniela, Bettegowda, Chetan, Zhu, Jay-Jiguang, Iwamoto, Fabio, Placantonakis, Dimitris, Kim, Lyndon, Elder, Brad, Kaptain, George, Cachia, David, Moshel, Yaron, Brem, Steven, Piccioni, David, Landolfi, Joseph, Chen, Clark C., Gruber, Harry, Rao, Aliz R., Hogan, Daniel, Accomando, William, Ostertag, Derek, Montellano, Tiffany T., Kheoh, Thian, Kabbinavar, Fairooz, Vogelbaum, Michael A.
Publicat 2020Text -
15
Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findin... per Shi, Qian, de Gramont, Aimery, Grothey, Axel, Zalcberg, John, Chibaudel, Benoist, Schmoll, Hans-Joachim, Seymour, Matthew T., Adams, Richard, Saltz, Leonard, Goldberg, Richard M., Punt, Cornelis J.A., Douillard, Jean-Yves, Hoff, Paulo M., Hecht, Joel Randolph, Hurwitz, Herbert, Díaz-Rubio, Eduardo, Porschen, Rainer, Tebbutt, Niall C., Fuchs, Charles, Souglakos, John, Falcone, Alfredo, Tournigand, Christophe, Kabbinavar, Fairooz F., Heinemann, Volker, Van Cutsem, Eric, Bokemeyer, Carsten, Buyse, Marc, Sargent, Daniel J.
Publicat 2015Text -
16
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database... per Renfro, Lindsay A., Goldberg, Richard M., Grothey, Axel, Sobrero, Alberto, Adams, Richard, Seymour, Matthew T., Heinemann, Volker, Schmoll, Hans-Joachim, Douillard, Jean-Yves, Hurwitz, Herbert, Fuchs, Charles S., Diaz-Rubio, Eduardo, Porschen, Rainer, Tournigand, Christophe, Chibaudel, Benoist, Hoff, Paulo M., Kabbinavar, Fairooz F., Falcone, Alfredo, Tebbutt, Niall C., Punt, Cornelis J.A., Hecht, J. Randolph, Souglakos, John, Bokemeyer, Carsten, Van Cutsem, Eric, Saltz, Leonard, de Gramont, Aimery, Sargent, Daniel J.
Publicat 2017Text -
17
Evaluation of Continuous Tumor-Size–Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer per Burzykowski, Tomasz, Coart, Elisabeth, Saad, Everardo D., Shi, Qian, Sommeijer, Dirkje W., Bokemeyer, Carsten, Díaz-Rubio, Eduardo, Douillard, Jean-Yves, Falcone, Alfredo, Fuchs, Charles S., Goldberg, Richard M., Hecht, J. Randolph, Hoff, Paulo M., Hurwitz, Herbert, Kabbinavar, Fairooz F., Koopman, Miriam, Maughan, Timothy S., Punt, Cornelis J. A., Saltz, Leonard, Schmoll, Hans-Joachim, Seymour, Matthew T., Tebbutt, Niall C., Tournigand, Christophe, Van Cutsem, Eric, de Gramont, Aimery, Zalcberg, John R., Buyse, Marc
Publicat 2019Text -
18
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis per Yin, Jun, Dawood, Shaheenah, Cohen, Romain, Meyers, Jeff, Zalcberg, John, Yoshino, Takayuki, Seymour, Matthew, Maughan, Tim, Saltz, Leonard, Van Cutsem, Eric, Venook, Alan, Schmoll, Hans-Joachim, Goldberg, Richard, Hoff, Paulo, Hecht, J. Randolph, Hurwitz, Herbert, Punt, Cornelis, Diaz Rubio, Eduard, Koopman, Miriam, Cremolini, Chiara, Heinemann, Volker, Tournigard, Christophe, Bokemeyer, Carsten, Fuchs, Charles, Tebbutt, Niall, Souglakos, John, Doulliard, Jean-Yves, Kabbinavar, Fairooz, Chibaudel, Benoist, de Gramont, Aimery, Shi, Qian, Grothey, Axel, Adams, Richard
Publicat 2021Text -
19
The High-Dose Aldesleukin “Select” Trial: A Trial to Prospectively Validate Predictive Models of Response Treatment in Patients with Metastatic Renal Cell Carcinoma per McDermott, David F., Cheng, Su-Chun, Signoretti, Sabina, Margolin, Kim A., Clark, Joseph I., Sosman, Jeffrey A., Dutcher, Janice P., Logan, Theodore F., Curti, Brendan D., Ernstoff, Marc S., Appleman, Leonard, Wong, Michael K.K., Khushalani, Nikhil I., Oleksowicz, Leslie, Vaishampayan, Ulka N., Mier, James W., Panka, David J., Bhatt, Rupal S., Bailey, Alexandra S., Leibovich, Bradley C., Kwon, Eugene D., Kabbinavar, Fairooz F., Belldegrun, Arie S., Figlin, Robert A., Pantuck, Allan J., Regan, Meredith M., Atkins, Michael B.
Publicat 2014Text -
20
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project per Sjoquist, Katrin M, Renfro, Lindsay A, Simes, R John, Tebbutt, Niall C, Clarke, Stephen, Seymour, Matthew T, Adams, Richard, Maughan, Timothy S, Saltz, Leonard, Goldberg, Richard M, Schmoll, Hans-Joachim, Van Cutsem, Eric, Douillard, Jean-Yves, Hoff, Paulo M, Hecht, Joel Randolph, Tournigand, Christophe, Punt, Cornelis J A, Koopman, Miriam, Hurwitz, Herbert, Heinemann, Volker, Falcone, Alfredo, Porschen, Rainer, Fuchs, Charles, Diaz-Rubio, Eduardo, Aranda, Enrique, Bokemeyer, Carsten, Souglakos, Ioannis, Kabbinavar, Fairooz F, Chibaudel, Benoist, Meyers, Jeffrey P, Sargent, Daniel J, de Gramont, Aimery, Zalcberg, John R
Publicat 2017Text